Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)
Condition: Relapsing Multiple Sclerosis Interventions: Drug: Evobrutinib; Drug: Placebo (match to Teriflunomide); Drug: Teriflunomide; Drug: Placebo (match to Evobrutinib) Sponsors: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany; EMD Serono Research & Development Institute, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials